Chinese herbal medicine composition for treating female infertility

A Chinese herbal medicine composition and infertility technology, which can be applied in the direction of drug combination, disease, medical formula, etc., and can solve the problems of different treatment mechanisms and curative effects

Inactive Publication Date: 2018-07-31
殷永华
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, there are many traditional Chinese medicine prescriptions for treating infertility, but the treatment mechanisms are different in emphasis and the curative effects are different

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese herbal medicine composition for treating female infertility

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The Chinese herbal medicine composition for the treatment of female infertility is prepared from the following raw materials in parts by weight (the dose of a drug): 50g of Lixuedan, 40g of Rosa laevigata, 30g of madder root, 30g of Rosa roxburghii root, 20g of motherwort, 20g of Buliu Xing, 20g of Sagittarius, 20g of Celosia, 15g of Rhododendron, 15g of Rose, and 15g of sweet wine.

[0027] Preparation:

[0028] (1) Weigh each API according to the formula quantity;

[0029] (2) Add water to the prepared medicine. The weight ratio of water to medicine is 800:1-2. First boil on high heat and then turn off low heat for 20-30 minutes. Filter, cool, pack, add and cook when taking of rum.

Embodiment 2

[0031] The Chinese herbal medicine composition for the treatment of female infertility is prepared from the following raw materials in parts by weight (the dose of a drug): 50g of Lixue Dan, 30g of Fructus Rosa, 20g of Rubia Root, 20g of Rosa Rosa Root, 15g of Motherwort, Wang 15g of Buliu Xing, 15g of Sagittarius Sinensis, 15g of Celosia, 10g of Rhododendron, and 10g of Chinese Rose.

[0032] The preparation method of the Chinese herbal medicine for treating female infertility is as in Example 1.

[0033] The prescription of the present invention is obtained by decades of research, exploration and clinical practice of the inventor's ancestors and fathers. The inventor has carried out statistics and analysis to the treatment case and therapeutic effect of these years, specifically as follows:

[0034] 1. Clinical data: 160 cases of infertility patients, including 43 cases of primary infertility and 117 cases of secondary infertility, aged 23-40 years, the longest course of di...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Chinese herbal medicine composition for treating female infertility, which is prepared from the following raw materials in parts by weight: 30 to 50 parts of herb of ajuga nipponensis, 30 to 50 parts of fructus rosae laevigatae, 15 to 30 parts of radix rubiae, 15 to 30 parts of rosa roxbunghii root, 10 to 20 parts of motherwort herb, 10 to 20 parts of cowherb seed, 10 to20 parts of caulis sargentodoxae, 10 to 20 parts of cockscomb flower, 5 to 15 parts of herba hyperici przewalskii, 5 to 15 parts of Chinese rose flower and 0 to 20 parts of sweet wine. The Chinese herbal medicine composition can be used for treating both internally and externally, culturing the foundation and strengthening the vitality; through the thorough recovery of the functions of uterus, fallopian tube and endocrine system, the female infertility can be treated, and the cure rate can reach up to 88% or above.

Description

technical field [0001] The invention relates to a Chinese herbal medicine composition for treating female infertility, and belongs to the technical field of Chinese herbal medicine pharmacy. Background technique [0002] Female infertility refers to a disease in which a woman of childbearing age has lived together for more than 2 years after marriage or her last pregnancy, and the man’s reproductive function is normal. It is primary infertility, and those who have had childbirth or miscarriage and have been infertile for more than 2 consecutive years are called secondary infertility. The specific clinical manifestations of female infertility are: abnormal menstruation, abnormal breast and secretion, vaginal inflammatory disease, various symptoms before and after menstruation, endometrial growth retardation, uterine dysplasia and deformity, and severe malnutrition. The incidence of infertility accounts for about 10% of women of reproductive age. The increasing trend of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/74A61P15/08
CPCA61K36/185A61K36/21A61K36/36A61K36/38A61K36/53A61K36/533A61K36/738A61K36/74A61P15/08A61K2300/00
Inventor 殷永华
Owner 殷永华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap